## TJX: TJX Companies, Inc. (The) - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -2.3% below STRENGTH zone (3.0-6.0%); PEG 2.95 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.0% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($144.50)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 0)

**1. Loomis Sayles & Co. L P Takes $7.04 Million Position in The TJX Companies, Inc. $TJX**
- Source: MarketBeat | 20251202T120357 | Somewhat-Bullish | Relevance: 99%
- Loomis Sayles & Co. L P has acquired a new position in The TJX Companies, Inc. (NYSE:TJX) valued at approximately $7.04 million in Q2 2025. This article details institutional investor activity, stock performance metrics, recent earnings, dividend announcements, insider trades, and analyst ratings for TJX.

**2. Van Hulzen Asset Management LLC Acquires 16,449 Shares of The TJX Companies, Inc. $TJX**
- Source: MarketBeat | 20251202T135947 | Somewhat-Bullish | Relevance: 99%
- Van Hulzen Asset Management LLC increased its stake in The TJX Companies by 51.1%, acquiring an additional 16,449 shares to hold a total of 48,655 shares valued at approximately $6.01 million. This increase follows TJX Companies reporting stronger-than-expected Q3 earnings and revenue, and providing positive Q4 and FY2026 guidance. Despite some insider selling, analysts maintain a consensus "Buy" rating for TJX with a target price of $158.90.

**3. Panagora Asset Management Inc. Sells 920,606 Shares of The TJX Companies, Inc. $TJX**
- Source: MarketBeat | 20251201T124859 | Neutral | Relevance: 99%
- Panagora Asset Management Inc. significantly reduced its stake in The TJX Companies, Inc. (NYSE:TJX) by selling 920,606 shares, decreasing its holdings by 69.1%. This move leaves Panagora with 412,580 shares valued at $50.95 million. Other institutional investors also adjusted their positions in TJX, which saw its stock open at $152.45, with a market cap of $169.67 billion, and analysts maintaining generally positive ratings.

**4. The TJX Companies, Inc. $TJX Shares Sold by BLI Banque de Luxembourg Investments**
- Source: MarketBeat | 20251130T084118 | Somewhat-Bullish | Relevance: 99%
- BLI Banque de Luxembourg Investments reduced its stake in The TJX Companies, Inc. (NYSE:TJX) by 19.5% in Q2 2025, selling over 100,000 shares. Other institutional investors also adjusted their positions, while insiders like CEO Ernie Herrman and Director Amy B. Lane sold a significant number of shares. The article also provides details on TJX's recent earnings, financial metrics, and current analyst ratings.

**5. Arrowstreet Capital Limited Partnership Has $666.41 Million Stock Position in The TJX Companies, Inc. $TJX**
- Source: MarketBeat | 20251202T083553 | Bullish | Relevance: 98%
- Arrowstreet Capital Limited Partnership significantly increased its stake in The TJX Companies, Inc. by 27.2% in the second quarter, now holding 5,396,443 shares valued at approximately $666.41 million. This increase is part of a broader trend of institutional investment in TJX, with other major firms like Vanguard Group and Geode Capital Management also holding substantial positions. The article details recent financial performance, analyst ratings, and insider transactions for TJX Companies, indicating a positive outlook from the investment community.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 15, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Guggenheim | $175 | $0 | 0% |
| 2025-12-04 | Barclays | $172 | $168 | +2% |
| 2025-12-04 | Baird | $165 | $160 | +3% |
| 2025-12-04 | Telsey Advisory | $170 | $170 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Guggenheim | init | Buy |
| 2025-12-04 | Barclays | main | Overweight |
| 2025-12-04 | Baird | main | Outperform |
| 2025-12-04 | Telsey Advisory | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($8.23M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.8%)
- Blackrock Inc.: 9.1% (+1.4%)
- State Street Corpora: 4.3% (-0.8%)
- JPMORGAN CHASE & CO: 3.5% (+80.3%)
- FMR, LLC: 3.0% (-0.7%)

### Key Risks

1. Insider selling cluster: $8.2M in recent transactions.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 15 raises (avg +5%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.95 signals overvaluation risk, limited margin of safety. Forward P/E 29.2x stretched relative to 10% growth. Quality metrics strong (ROE 58%, ROA 12%). Balance sheet: $1.0B free cash flow. Insider selling cluster ($8.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $173.3B |
| Beta | 0.76 |
| 52W Range | $112.10 - $156.40 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.95 |
| Forward P/E | 29.2 |
| Current P/E | 32.1 |
| YoY Growth | 9.9% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 1.8% to -2.3% (-4.0% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 5.3pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -2.30% (CS: 32) | Weak |
| RSI_14 | 58.3 | Neutral |
| MACD Histogram | 0.29 | Bullish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.039x | Above |
| vs SMA200 | 1.140x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $150.02
- **Stop Loss:** $144.50 (3.7% risk)
- **Target:** $155.54 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 181
- **Position Value:** $27,153.62
- **Portfolio %:** 27.15%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-25 (Est: $1.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $1.22 | $1.28 | +5.0% |
| 2025Q3 | $1.01 | $1.10 | +8.5% |
| 2025Q2 | $0.91 | $0.92 | +0.8% |
| 2025Q1 | $1.17 | $1.23 | +5.3% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*